174 related articles for article (PubMed ID: 27450003)
21. Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.
Driesen M; Kondo Y; de Jong BC; Torrea G; Asnong S; Desmaretz C; Mostofa KSM; Tahseen S; Whitfield MG; Cirillo DM; Miotto P; Cabibbe AM; Rigouts L
Clin Microbiol Infect; 2018 Jan; 24(1):60-64. PubMed ID: 28587904
[TBL] [Abstract][Full Text] [Related]
22. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.
Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1486-90. PubMed ID: 24125455
[TBL] [Abstract][Full Text] [Related]
23. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
Yüksel P; Tansel O
New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
[TBL] [Abstract][Full Text] [Related]
24. Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.
Maningi NE; Daum LT; Rodriguez JD; Mphahlele M; Peters RP; Fischer GW; Chambers JP; Fourie PB
J Clin Microbiol; 2015 Dec; 53(12):3779-83. PubMed ID: 26378284
[TBL] [Abstract][Full Text] [Related]
25. Detection of pyrazinamide resistance of Mycobacterium tuberculosis using nicotinamide as a surrogate.
Hu Y; Wu X; Luo J; Fu Y; Zhao L; Ma Y; Li Y; Liang Q; Shang Y; Huang H
Clin Microbiol Infect; 2017 Nov; 23(11):835-838. PubMed ID: 28411185
[TBL] [Abstract][Full Text] [Related]
26. Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
Ngabonziza JCS; Diallo AB; Tagliani E; Diarra B; Kadanga AE; Togo ACG; Thiam A; de Rijk WB; Alagna R; Houeto S; Ba F; Dagnra AY; Ivan E; Affolabi D; Schwoebel V; Trebucq A; de Jong BC; Rigouts L; Daneau G;
PLoS One; 2017; 12(10):e0187211. PubMed ID: 29088294
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.
Xu P; Wu J; Yang C; Luo T; Shen X; Zhang Y; Nsofor CA; Zhu G; Gicquel B; Gao Q
Tuberculosis (Edinb); 2016 May; 98():56-61. PubMed ID: 27156619
[TBL] [Abstract][Full Text] [Related]
28. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM
BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test.
Aono A; Hirano K; Hamasaki S; Abe C
Diagn Microbiol Infect Dis; 2002 Dec; 44(4):347-52. PubMed ID: 12543539
[TBL] [Abstract][Full Text] [Related]
31. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
[TBL] [Abstract][Full Text] [Related]
32. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis.
Davies AP; Billington OJ; McHugh TD; Mitchison DA; Gillespie SH
J Clin Microbiol; 2000 Oct; 38(10):3686-8. PubMed ID: 11015384
[TBL] [Abstract][Full Text] [Related]
33. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
Velásquez GE; Calderon RI; Mitnick CD; Becerra MC; Huang CC; Zhang Z; Contreras CC; Yataco RM; Galea JT; Lecca LW; Murray MB
Antimicrob Agents Chemother; 2016 Nov; 60(11):6766-6773. PubMed ID: 27600032
[TBL] [Abstract][Full Text] [Related]
34. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
Zhang Y; Permar S; Sun Z
J Med Microbiol; 2002 Jan; 51(1):42-49. PubMed ID: 11800471
[TBL] [Abstract][Full Text] [Related]
35. Ability of the MeltPro MTB/PZA Assay to Detect Susceptibility to Pyrazinamide in Rifampin-Resistant Tuberculosis Patients.
Li R; Li Y; Chen X; Jia L; Yu H; Huang Y; Wu Q; Xiao M; Ge S; Zhang Y; Feng Z; Li Q; Xu Y; Shi W; Sun F; Zhang W
Microbiol Spectr; 2023 Jun; 11(3):e0483622. PubMed ID: 37162355
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.
Muthaiah M; Jagadeesan S; Ayalusamy N; Sreenivasan M; Prabhu SS; Muthuraj U; Senthilkumar K; Veerappan S
Int J Mol Sci; 2010 Jul; 11(7):2670-80. PubMed ID: 20717529
[TBL] [Abstract][Full Text] [Related]
37. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
Miotto P; Cabibbe AM; Feuerriegel S; Casali N; Drobniewski F; Rodionova Y; Bakonyte D; Stakenas P; Pimkina E; Augustynowicz-Kopeć E; Degano M; Ambrosi A; Hoffner S; Mansjö M; Werngren J; Rüsch-Gerdes S; Niemann S; Cirillo DM
mBio; 2014 Oct; 5(5):e01819-14. PubMed ID: 25336456
[TBL] [Abstract][Full Text] [Related]
38. A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant
Rueda D; Furukawa R; Fuentes P; Comina G; Rey De Castro NG; Requena D; Gilman RH; Sheen P; Zimic M
Int J Mycobacteriol; 2018; 7(3):275-281. PubMed ID: 30198510
[TBL] [Abstract][Full Text] [Related]
39. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
[TBL] [Abstract][Full Text] [Related]
40. Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.
Stehr M; Elamin AA; Singh M
Expert Rev Anti Infect Ther; 2015 May; 13(5):593-603. PubMed ID: 25746054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
